| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 14 | 1996 | 104 | 0.850 |
Why?
|
| Amniocentesis | 15 | 1999 | 31 | 0.610 |
Why?
|
| Fetal Diseases | 7 | 1999 | 81 | 0.600 |
Why?
|
| Pregnancy | 41 | 2003 | 2894 | 0.590 |
Why?
|
| Mosaicism | 8 | 1996 | 67 | 0.540 |
Why?
|
| Chorionic Villi Sampling | 10 | 1999 | 13 | 0.500 |
Why?
|
| Trisomy | 7 | 1997 | 55 | 0.420 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2003 | 152 | 0.390 |
Why?
|
| Decision Support Techniques | 5 | 1999 | 160 | 0.380 |
Why?
|
| Chromosome Aberrations | 8 | 1996 | 387 | 0.350 |
Why?
|
| Sex Chromosome Aberrations | 7 | 1991 | 19 | 0.330 |
Why?
|
| Disorders of Sex Development | 4 | 1992 | 18 | 0.310 |
Why?
|
| alpha-Fetoproteins | 3 | 1999 | 45 | 0.270 |
Why?
|
| Y Chromosome | 3 | 1991 | 28 | 0.250 |
Why?
|
| Fetal Growth Retardation | 3 | 2000 | 66 | 0.250 |
Why?
|
| X Chromosome | 3 | 1989 | 152 | 0.230 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2003 | 20 | 0.230 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2003 | 8 | 0.230 |
Why?
|
| Methotrexate | 1 | 2003 | 249 | 0.220 |
Why?
|
| Congenital Abnormalities | 5 | 1998 | 63 | 0.200 |
Why?
|
| Mass Screening | 2 | 2018 | 618 | 0.200 |
Why?
|
| Female | 52 | 2020 | 44533 | 0.200 |
Why?
|
| Breast Neoplasms | 4 | 2020 | 2903 | 0.180 |
Why?
|
| Adult | 33 | 2020 | 25648 | 0.180 |
Why?
|
| Anus, Imperforate | 1 | 1999 | 11 | 0.180 |
Why?
|
| Complementary Therapies | 1 | 2020 | 54 | 0.170 |
Why?
|
| Genetic Diseases, Inborn | 5 | 1998 | 101 | 0.170 |
Why?
|
| Choroid Plexus | 1 | 1997 | 14 | 0.160 |
Why?
|
| Consanguinity | 2 | 1995 | 73 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 18 | 3 | 1997 | 42 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 1987 | 79 | 0.150 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 200 | 0.150 |
Why?
|
| Humans | 58 | 2020 | 86644 | 0.150 |
Why?
|
| Cysts | 1 | 1997 | 104 | 0.140 |
Why?
|
| Genetic Testing | 4 | 1998 | 535 | 0.140 |
Why?
|
| Abnormalities, Multiple | 4 | 1994 | 232 | 0.130 |
Why?
|
| Maternal Age | 7 | 1998 | 44 | 0.130 |
Why?
|
| Choice Behavior | 2 | 1998 | 160 | 0.130 |
Why?
|
| Genetic Counseling | 3 | 1998 | 100 | 0.130 |
Why?
|
| Chromosome Disorders | 6 | 1996 | 114 | 0.130 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 394 | 0.120 |
Why?
|
| Karyotyping | 6 | 1997 | 250 | 0.120 |
Why?
|
| Gastritis, Hypertrophic | 1 | 1993 | 4 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 3362 | 0.120 |
Why?
|
| Chorionic Villi | 3 | 1996 | 11 | 0.120 |
Why?
|
| Infant, Newborn | 9 | 2000 | 2380 | 0.120 |
Why?
|
| Down Syndrome | 1 | 1993 | 53 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1993 | 76 | 0.110 |
Why?
|
| Histocompatibility | 1 | 1993 | 71 | 0.110 |
Why?
|
| Chimera | 1 | 1992 | 56 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 1994 | 454 | 0.100 |
Why?
|
| Amniotic Fluid | 4 | 1996 | 30 | 0.100 |
Why?
|
| HLA Antigens | 4 | 2000 | 232 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 1991 | 78 | 0.090 |
Why?
|
| Chorion | 1 | 1990 | 13 | 0.090 |
Why?
|
| Ploidies | 1 | 1990 | 40 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1989 | 79 | 0.090 |
Why?
|
| Lymphangioma | 1 | 1989 | 15 | 0.090 |
Why?
|
| Pigment Epithelium of Eye | 2 | 1999 | 13 | 0.090 |
Why?
|
| Genes, MHC Class I | 2 | 2000 | 48 | 0.090 |
Why?
|
| Urinary Tract | 1 | 1989 | 34 | 0.080 |
Why?
|
| Pregnancy, Multiple | 3 | 1983 | 37 | 0.080 |
Why?
|
| Abortion, Induced | 3 | 2003 | 120 | 0.080 |
Why?
|
| Ultrasonography | 6 | 1989 | 695 | 0.080 |
Why?
|
| Turner Syndrome | 1 | 1988 | 27 | 0.080 |
Why?
|
| Urinary Bladder Diseases | 1 | 1988 | 41 | 0.080 |
Why?
|
| Fallopian Tubes | 1 | 2008 | 41 | 0.080 |
Why?
|
| Ovariectomy | 1 | 2008 | 81 | 0.080 |
Why?
|
| Hydrops Fetalis | 2 | 2003 | 16 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2000 | 203 | 0.080 |
Why?
|
| Pulmonary Artery | 1 | 1989 | 306 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 229 | 0.080 |
Why?
|
| Abortion, Spontaneous | 4 | 1998 | 66 | 0.070 |
Why?
|
| Genes, BRCA2 | 1 | 2008 | 160 | 0.070 |
Why?
|
| Prader-Willi Syndrome | 2 | 1996 | 8 | 0.070 |
Why?
|
| Genes, BRCA1 | 1 | 2008 | 192 | 0.070 |
Why?
|
| Abortion, Habitual | 2 | 1983 | 33 | 0.070 |
Why?
|
| Metabolism, Inborn Errors | 2 | 1983 | 30 | 0.070 |
Why?
|
| Male | 18 | 1998 | 40966 | 0.070 |
Why?
|
| Testicular Hydrocele | 1 | 1984 | 3 | 0.070 |
Why?
|
| Parents | 1 | 1988 | 272 | 0.060 |
Why?
|
| Fibroblasts | 1 | 1988 | 729 | 0.060 |
Why?
|
| Acetylcholinesterase | 1 | 1984 | 47 | 0.060 |
Why?
|
| Genetic Linkage | 2 | 1983 | 623 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 1999 | 455 | 0.060 |
Why?
|
| Pregnancy, High-Risk | 4 | 1996 | 16 | 0.060 |
Why?
|
| von Willebrand Diseases | 1 | 1983 | 6 | 0.060 |
Why?
|
| Insemination, Artificial, Heterologous | 1 | 1983 | 2 | 0.060 |
Why?
|
| Insemination, Artificial | 1 | 1983 | 16 | 0.060 |
Why?
|
| Uterine Diseases | 1 | 1983 | 19 | 0.060 |
Why?
|
| Klinefelter Syndrome | 1 | 1983 | 4 | 0.060 |
Why?
|
| Leg Ulcer | 1 | 1983 | 7 | 0.060 |
Why?
|
| Mucopolysaccharidosis VII | 1 | 2003 | 1 | 0.060 |
Why?
|
| Middle Aged | 8 | 2020 | 25028 | 0.060 |
Why?
|
| Coloring Agents | 1 | 1983 | 64 | 0.060 |
Why?
|
| Mutation | 2 | 2018 | 3968 | 0.050 |
Why?
|
| Leg | 1 | 1983 | 137 | 0.050 |
Why?
|
| Hematologic Diseases | 1 | 1983 | 79 | 0.050 |
Why?
|
| Limb Deformities, Congenital | 3 | 1998 | 21 | 0.050 |
Why?
|
| Sex Chromosomes | 1 | 1983 | 57 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2003 | 285 | 0.050 |
Why?
|
| Risk Factors | 4 | 1994 | 5417 | 0.050 |
Why?
|
| Biopsy | 2 | 2018 | 1163 | 0.050 |
Why?
|
| Probability | 3 | 1994 | 355 | 0.050 |
Why?
|
| Kidney | 2 | 1994 | 1241 | 0.050 |
Why?
|
| Uterus | 1 | 1983 | 215 | 0.050 |
Why?
|
| Base Sequence | 4 | 1995 | 2330 | 0.050 |
Why?
|
| Genitalia, Female | 2 | 1992 | 25 | 0.050 |
Why?
|
| Crohn Disease | 1 | 1987 | 730 | 0.050 |
Why?
|
| Physicians | 2 | 1999 | 673 | 0.050 |
Why?
|
| Time Factors | 3 | 1997 | 5210 | 0.050 |
Why?
|
| Fetal Death | 3 | 2003 | 56 | 0.050 |
Why?
|
| Pedigree | 3 | 1998 | 966 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 1995 | 3030 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2003 | 336 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2000 | 205 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 1996 | 63 | 0.040 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1999 | 11 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2018 | 4214 | 0.040 |
Why?
|
| Health Behavior | 1 | 2020 | 183 | 0.040 |
Why?
|
| Follow-Up Studies | 4 | 1999 | 3640 | 0.040 |
Why?
|
| Fetal Viability | 1 | 1998 | 9 | 0.040 |
Why?
|
| Risk | 3 | 1987 | 674 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 1994 | 1991 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 2 | 1996 | 66 | 0.040 |
Why?
|
| Retina | 1 | 1999 | 213 | 0.040 |
Why?
|
| Angelman Syndrome | 1 | 1996 | 7 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2000 | 246 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1996 | 20 | 0.040 |
Why?
|
| Cell Division | 3 | 1999 | 696 | 0.040 |
Why?
|
| Foot Deformities, Congenital | 2 | 1989 | 10 | 0.040 |
Why?
|
| Hand Deformities, Congenital | 2 | 1989 | 15 | 0.040 |
Why?
|
| Diet | 1 | 2020 | 443 | 0.040 |
Why?
|
| Exercise | 1 | 2020 | 315 | 0.040 |
Why?
|
| Aged | 5 | 2020 | 18415 | 0.040 |
Why?
|
| Brain Diseases | 1 | 1997 | 180 | 0.030 |
Why?
|
| Cells, Cultured | 6 | 1999 | 2818 | 0.030 |
Why?
|
| Mucopolysaccharidosis IV | 1 | 1995 | 2 | 0.030 |
Why?
|
| Autoantigens | 1 | 1996 | 127 | 0.030 |
Why?
|
| Obstetrics | 1 | 1998 | 120 | 0.030 |
Why?
|
| Genetic Carrier Screening | 2 | 2008 | 60 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 1997 | 195 | 0.030 |
Why?
|
| Intestine, Small | 2 | 1995 | 303 | 0.030 |
Why?
|
| Syndrome | 2 | 1989 | 446 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 274 | 0.030 |
Why?
|
| Opsonin Proteins | 1 | 1975 | 6 | 0.030 |
Why?
|
| Platelet Adhesiveness | 1 | 1975 | 8 | 0.030 |
Why?
|
| Cytidine Deaminase | 1 | 1995 | 43 | 0.030 |
Why?
|
| Apolipoproteins B | 2 | 1995 | 38 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 39 | 0.030 |
Why?
|
| Plasma | 1 | 1975 | 50 | 0.030 |
Why?
|
| Mammography | 1 | 2018 | 463 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 1995 | 185 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 1995 | 265 | 0.030 |
Why?
|
| Blood Platelets | 1 | 1975 | 149 | 0.030 |
Why?
|
| Alleles | 2 | 2000 | 1128 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 3 | 1998 | 63 | 0.030 |
Why?
|
| Leukocytes | 1 | 1975 | 202 | 0.030 |
Why?
|
| DNA | 3 | 1998 | 1294 | 0.030 |
Why?
|
| Estriol | 1 | 1993 | 8 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2013 | 63 | 0.030 |
Why?
|
| Steroids | 1 | 1975 | 177 | 0.030 |
Why?
|
| Health Services Research | 1 | 1994 | 136 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 1993 | 72 | 0.030 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 1993 | 16 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2013 | 36 | 0.030 |
Why?
|
| Decidua | 1 | 1993 | 19 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 1939 | 0.030 |
Why?
|
| HLA-DQ Antigens | 1 | 1993 | 52 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 121 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2013 | 95 | 0.030 |
Why?
|
| Urethra | 1 | 1994 | 113 | 0.030 |
Why?
|
| Birth Weight | 1 | 1993 | 145 | 0.030 |
Why?
|
| Lymphocytes | 2 | 1996 | 464 | 0.030 |
Why?
|
| Neural Tube Defects | 2 | 1983 | 43 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1995 | 276 | 0.030 |
Why?
|
| Health Policy | 1 | 1994 | 180 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2013 | 261 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 1998 | 582 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1995 | 403 | 0.030 |
Why?
|
| Anxiety | 1 | 1994 | 287 | 0.030 |
Why?
|
| DNA Methylation | 1 | 1996 | 628 | 0.030 |
Why?
|
| Neoplasms | 1 | 1987 | 2898 | 0.030 |
Why?
|
| Cell Line | 3 | 1996 | 2468 | 0.030 |
Why?
|
| Abortion, Therapeutic | 1 | 1991 | 11 | 0.020 |
Why?
|
| Dysgerminoma | 1 | 1990 | 7 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 623 | 0.020 |
Why?
|
| Gonads | 1 | 1990 | 19 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1993 | 272 | 0.020 |
Why?
|
| Decision Trees | 1 | 1991 | 63 | 0.020 |
Why?
|
| United States | 3 | 1994 | 6672 | 0.020 |
Why?
|
| Infant | 1 | 1997 | 3047 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1997 | 3612 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1990 | 100 | 0.020 |
Why?
|
| Adolescent | 3 | 2000 | 8981 | 0.020 |
Why?
|
| Fetal Blood | 1 | 1990 | 90 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 2271 | 0.020 |
Why?
|
| Fetus | 3 | 1996 | 226 | 0.020 |
Why?
|
| HLA-G Antigens | 2 | 2000 | 52 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 1995 | 1981 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2013 | 663 | 0.020 |
Why?
|
| Neck | 1 | 1989 | 100 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1992 | 1074 | 0.020 |
Why?
|
| Contrast Media | 1 | 2013 | 1078 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1989 | 217 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 5976 | 0.020 |
Why?
|
| Internationality | 1 | 1988 | 69 | 0.020 |
Why?
|
| Cohort Studies | 1 | 1994 | 2767 | 0.020 |
Why?
|
| Gonadal Dysgenesis | 1 | 1987 | 3 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 98 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2000 | 677 | 0.020 |
Why?
|
| Biomarkers | 1 | 1993 | 1718 | 0.020 |
Why?
|
| Gestational Age | 2 | 2003 | 311 | 0.020 |
Why?
|
| Prevalence | 1 | 1991 | 1239 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1993 | 1195 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1988 | 989 | 0.020 |
Why?
|
| Rabbits | 2 | 1999 | 636 | 0.020 |
Why?
|
| Phenotype | 1 | 1992 | 2378 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1984 | 216 | 0.020 |
Why?
|
| Haploidy | 1 | 1983 | 31 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1983 | 39 | 0.010 |
Why?
|
| Mullerian Ducts | 1 | 1983 | 17 | 0.010 |
Why?
|
| Urogenital Abnormalities | 1 | 1983 | 19 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1983 | 144 | 0.010 |
Why?
|
| Tay-Sachs Disease | 1 | 1982 | 6 | 0.010 |
Why?
|
| Fetoscopy | 1 | 1982 | 8 | 0.010 |
Why?
|
| Hemoglobinopathies | 1 | 1982 | 10 | 0.010 |
Why?
|
| Jurisprudence | 1 | 1982 | 25 | 0.010 |
Why?
|
| Computers | 1 | 1983 | 112 | 0.010 |
Why?
|
| Genetic Techniques | 1 | 1982 | 72 | 0.010 |
Why?
|
| Decision Making | 1 | 1988 | 642 | 0.010 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1981 | 6 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1990 | 1920 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1982 | 112 | 0.010 |
Why?
|
| United Kingdom | 1 | 1981 | 164 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 1999 | 2705 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 744 | 0.010 |
Why?
|
| Canada | 1 | 1981 | 204 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 927 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1982 | 166 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 8489 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1995 | 1753 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1999 | 31 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1999 | 66 | 0.010 |
Why?
|
| Keratins | 1 | 1999 | 63 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 71 | 0.010 |
Why?
|
| B7-1 Antigen | 1 | 1999 | 75 | 0.010 |
Why?
|
| Microspheres | 1 | 1999 | 101 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1998 | 51 | 0.010 |
Why?
|
| Human Genome Project | 1 | 1998 | 19 | 0.010 |
Why?
|
| Liver | 2 | 1995 | 1230 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1999 | 90 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1999 | 363 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1998 | 303 | 0.010 |
Why?
|
| Genetics, Medical | 1 | 1998 | 52 | 0.010 |
Why?
|
| snRNP Core Proteins | 1 | 1996 | 9 | 0.010 |
Why?
|
| Point Mutation | 1 | 1998 | 246 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 543 | 0.010 |
Why?
|
| Placenta | 1 | 1998 | 175 | 0.010 |
Why?
|
| CpG Islands | 1 | 1996 | 151 | 0.010 |
Why?
|
| Attitude to Health | 1 | 1998 | 220 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1983 | 1351 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 1999 | 482 | 0.010 |
Why?
|
| APOBEC-1 Deaminase | 1 | 1995 | 2 | 0.010 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 1995 | 4 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1996 | 145 | 0.010 |
Why?
|
| Coenzyme A Ligases | 1 | 1995 | 7 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1995 | 41 | 0.010 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1975 | 6 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1975 | 29 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1998 | 567 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1975 | 44 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1998 | 306 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1975 | 43 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1997 | 678 | 0.010 |
Why?
|
| Prednisone | 1 | 1975 | 258 | 0.010 |
Why?
|
| Models, Psychological | 1 | 1994 | 157 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1975 | 298 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1999 | 1065 | 0.010 |
Why?
|
| CD3 Complex | 1 | 1993 | 135 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1993 | 220 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 1204 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1975 | 241 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 1998 | 610 | 0.010 |
Why?
|
| Catheterization | 1 | 1993 | 232 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1975 | 971 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1990 | 157 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1999 | 2501 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1993 | 295 | 0.010 |
Why?
|
| Plasmids | 1 | 1990 | 287 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1993 | 425 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1990 | 258 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1990 | 105 | 0.010 |
Why?
|
| Animals | 2 | 1999 | 26582 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 1376 | 0.000 |
Why?
|
| Child | 1 | 1995 | 6927 | 0.000 |
Why?
|
| Metaphase | 1 | 1982 | 25 | 0.000 |
Why?
|
| Chromosome Banding | 1 | 1982 | 74 | 0.000 |
Why?
|